Controlling antibiotic resistance in the ICU: Different bacteria, different strategies
Louis B. Rice, MD
Louis Stokes Cleveland VA Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH
Address: Louis B. Rice, MD, Medical Service 111(W), Louis Stokes Cleveland VA Medical Center, 10701 East Boulevard, Cleveland, OH 44106, E-mail: email@example.com
The author has indicated that he has received grant or research support from the Wyeth-Ayerst, Ortho-McNeil, and Elan companies, serves as a consultant for the Wyeth-Ayerst, Ortho-McNeil, Elan, and Merck companies, and is on the speakers’ bureaus of the Wyeth-Ayerst, Merck, and Elan companies.
ABSTRACTTo reduce antimicrobial resistance in the intensive care unit, hospitals are developing strategies such as improving infection control, adhering to prescribed formularies, requiring prior approval for using certain antibiotics, setting limits on the duration of antimicrobial therapy, and rotating the use of antimicrobial drugs on a regular schedule. Each strategy has theoretical benefits and limitations, but good data on their efficacy in controlling antimicrobial resistance are limited.